In the present study, we evaluated the plasma level of IL-17 among newly diagnosed and under-treatment SLE patients in correlation with the disease activity to elucidate the effect of glucocorticoids on Th17 response. The gene discussed is IL17A; the disease is systemic lupus erythematosus.